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A B S T R A C T
NMDA receptor-dependent synaptic plasticity has been proposed to be important for encoding of memories.
Consistent with this hypothesis, the non-competitive NMDA receptor antagonist, MK-801, has been found to
impair performance on tests of memory. Interpretation of some of these ﬁndings has, however, been complicated
by the fact that the drug-state of animals has diﬀered during encoding and tests of memory. Therefore, it is
possible that MK-801 may result in state-dependent retrieval or expression of memory rather than actually
impairing encoding itself. We tested this hypothesis in mice using tests of object recognition memory with a 24-
hour delay between the encoding and test phase. Mice received injections of either vehicle or MK-801 prior to
the encoding phase and the test phase. In Experiment 1, a low dose of MK-801 (0.01mg/kg) impaired perfor-
mance when the drug-state (vehicle or MK-801) of mice changed between encoding and test, but there was no
signiﬁcant eﬀect of MK-801 on encoding. In Experiment 2, a higher dose of MK-801 (0.1 mg/kg) failed to impair
object recognition memory when mice received the drug prior to both encoding and test compared to mice that
received vehicle. MK-801 did not aﬀect object exploration, but it did induce locomotor hyperactivity at the
higher dose. These results suggest that some previous demonstrations of MK-801 eﬀects may reﬂect a failure to
express or retrieve memory due to the state-dependency of memory rather than impaired encoding of memory.
1. Introduction
N-methyl-D-aspartate (NMDA) receptors, due to their role in the
putative learning mechanism long-term potentiation (Bliss &
Collingridge, 1993), have been proposed to be important for encoding
of memories (Riedel, Platt, & Micheau, 2003). Evidence for the role of
NMDA receptors in encoding has, in part, come from studies that have
examined the eﬀects of MK-801 on tests of memory. MK-801 (dizo-
cilpine) is a non-competitive and selective NMDA antagonist that has a
high aﬃnity towards NMDA receptors (Wong et al., 1986) and acts by
binding to NMDA receptors and blocking the channel pore in a use-
dependent manner. MK-801 has been shown to impair short-term
spontaneous object recognition memory (King et al., 2004; van der
Staay, Rutten, Erb, & Blokland, 2011), a form of memory reliant on the
perirhinal cortex (Ennaceur, Neave, & Aggleton, 1996). MK-801 has
been suggested to have the greatest eﬀect when the drug is
administered before the encoding phase (de Lima, Laranja, Bromberg,
Roesler, & Schroder, 2005; Nilsson, Hansson, Carlsson, & Carlsson,
2007) and doses as low as 0.01mg/kg have been found to impair
performance (de Lima et al., 2005). The eﬀect of the drug is less clear,
however, when given after the encoding phase or prior to the test, with
some studies (de Lima et al., 2005; Pichat et al., 2007) reporting im-
pairment of performance whilst other studies reported facilitating ef-
fects of the drug (Nilsson et al., 2007) on objection recognition
memory.
Studies that have attempted to dissociate the eﬀects of MK-801 on
encoding and retrieval of memory have, typically, separated the en-
coding and retrieval phases by a period of time after which it is unlikely
that the drug will still be eﬀective (e.g., 24 h). A problem with this
approach is that in order to isolate the eﬀects of a drug on a particular
stage of a memory procedure, animals are tested in a drug-state that
diﬀers from the drug-state during encoding. Therefore, if behavioral
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expression or retrieval of memory is dependent on animals being in the
same state as during encoding then a change of state will impair per-
formance (Girden & Culler, 1937). Previous research that has examined
the eﬀect of MK-801 on long-term object recognition, in which the
exposure and test phases are separated by a long period of time, have
failed to control for the state-dependency of memory. de Lima et al.
(2005) gave doses of 0.01 and 0.1mg/kg MK-801 20min before the
encoding phase and rats were tested 24 h later. Reductions in perfor-
mance were found with both doses. This raises the possibility that MK-
801 may not have impaired object memory encoding itself, but instead
aﬀected performance through altering the drug-state of animals. Con-
sistent with this possibility, MK-801 has been found to have state-de-
pendent eﬀects on performance on other learning and memory proce-
dures such as fear induced passive avoidance (Ceretta, Camera, Mello,
& Rubin, 2008; Flint, Noble, & Ulmen, 2013; Harrod, Flint, & Riccio,
2001) and appetitively rewarded instrumental responding (Jackson,
Koek, & Colpaert, 1992).
It is important to note that state-dependency of object recognition
memory performance is less likely to be an issue when memory is tested
after a relatively short interval, because the encoding and retrieval
stages of the test are likely to be conducted under the same drug-state.
For example, in the study by van der Staay et al. (2011) MK-801 was
given 30min before the encoding phase and rats were tested after a one
hour retention interval (see also King et al., 2004, in which MK801 was
given 40min before encoding and the retention interval was two
hours). Therefore, the signiﬁcant eﬀect of MK-801 on performance in
this experiment is unlikely to be due to a change in drug-state after this
short period of time. State-dependency is more likely to be an issue
when the interval between encoding and test is long enough to exceed
the duration of the eﬀect of drug.
In the present study, we tested whether MK-801 induced a state that
aﬀected performance of memory by testing long-term object recogni-
tion memory in mice. Mice were tested using a procedure that allows
for multiple tests of object recognition memory, which increases the
overall sensitivity of the measure (Ameen-Ali, Eacott, & Easton, 2012;
Chan et al., 2018). Mice were exposed to eight diﬀerent objects on day
1 and then on day 2 received a series of novelty preference tests, one for
each of the eight familiar objects, in which they were allowed to ex-
plore a familiar object and a novel object. A preference for exploring the
novel object over the familiar object demonstrates stimulus-speciﬁc
habituation of exploratory behavior towards the familiar object as a
result of a memory for the familiar object. In Experiment 1, we ex-
amined the eﬀect of a low dose of MK-801 (0.01 mg/kg) on state-de-
pendent, long-term object recognition memory. This dose has pre-
viously been reported to be suﬃcient to disrupt performance when
administered prior to the encoding phase of an object recognition
memory test in rats (de Lima et al., 2005). Mice received either MK-801
or vehicle prior to the exposure phase on day one and then received
either the same substance or the diﬀerent substance prior to the test on
day two. Therefore, the factors of drug-state at exposure and whether
the drug-state at test matched that of exposure were manipulated in a
factorial manner. In Experiment 2, we tested the eﬀect of a higher dose
of MK-801 (0.1 mg/kg). Mice received either MK-801 prior to both
exposure and test, or vehicle prior to both phases. Therefore, the drug-
state at both phases was the same and so performance in the test phase
cannot reﬂect the eﬀect of a switch between drug-states. In addition to
object exploration, we also measured path lengths during the procedure
in order to gauge whether the doses of MK-801 caused hyper-locomotor
activity.
2. Materials and methods
2.1. Subjects
Thirty-two female C57BL/6J mice, bred in Life Sciences Support
Unit at Durham University, were used in Experiments 1 and 2. Mice
were approximately 13 weeks old at the start of testing and their free-
feeding weights ranged between 15.9 and 22.6 g (mean=19.1 g). The
animals were housed in groups of four under diurnal conditions (lights
on: 7:00 am–7:00 pm). Prior to the start of the experiment, the weights
of the mice were reduced by being placed on a restricted diet. Mice
were then maintained at 85% of their free-feeding weights throughout
the experiment. Mice had ad libitum access to water in their home
cages. All procedures were in accordance with the United Kingdom
Animals Scientiﬁc Procedures Act (1986); under project license number
PPL 70/7785.
2.2. Drugs and injections
(+)-MK-801 hydrogen maleate (Sigma-Aldrich, UK) was dissolved
in saline (0.9% NaCl solution). Mice were injected intraperitoneally
with MK-801 or vehicle 30min before the exposure phase and test
phase. Doses of 0.01mg/kg and 0.1mg/kg MK-801, given in a volume
of 10mL/kg, were used in Experiments 1 and 2, respectively.
2.3. Apparatus
A rectangular arena (50 cm×42 cm×20 cm) divided into a
holding arena and an object arena was used (see Chan et al., 2018,
Fig. 1). Mice could move between the arenas through three guillotine
doors controlled by the experimenter. There was a central door (15 cm
wide) that allowed mice to move from the holding arena to the object
arena, and two side doors (10 cm wide) that allowed mice to return
from the object arena back to the holding arena. Objects were placed at
the top-left and top-right corner of the object arena approximately 3 cm
from the walls. Two food wells, one in each of the holding and object
arenas, were located in the middle of the end walls of the apparatus.
The apparatus was made of 10mm opal acrylic and the ﬂoors of the
apparatus comprised of a grey Lego® surface. The apparatus was cov-
ered by a clear Perspex roof (50 cm×42 cm). An overhead camera was
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Fig. 1. The eﬀect of 0.01mg/kg MK-801 on object
recognition memory. Mice received MK-801 or ve-
hicle prior to the exposure phase. In the test phase
the drug-state of mice was either the same or dif-
ferent from that during the exposure phase. Left
panel: Performance in the novelty preference test is
shown as a diﬀerence score (mean time spent ex-
ploring the novel objects minus the mean time
spent exploring the familiar objects). Scores above
zero indicate a novelty preference. Right panel:
Performance in the novelty preference test is shown
as a discrimination ratio (diﬀerence score divided
by mean total time spent exploring the objects in
the test phase). Error bars indicate SEM.
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ﬁxed at a height of 1.0m above the apparatus. The camera was con-
nected to a DVD-R recorder and a 22-inch screen to allow the experi-
menter to monitor the animals’ activity within the apparatus. The room
was illuminated by diﬀused lighting originating from a single table
lamp equipped with a 50 w lightbulb. White noise was continuously
played in the background throughout the experiment to mask extra-
neous noise. Various junk objects were used, which diﬀered in colour,
texture, shape and size. The objects were made of diﬀerent materials,
including ceramic, plastic, rubber, glass, metal and combinations of
those materials.
2.4. Procedure
2.4.1. Habituation and pre-training
Mice were exposed to the arena and a selection of objects (that were
not used subsequently in the experiments) over a period of seven days
and were trained to shuttle between the holding arena and the object
arena to consume 0.1mL sweetened condensed milk (Nestlé UK Ltd.,
UK) diluted 50% by volume with water. This procedure was used to
ensure that mice were motivated to repeatedly enter the holding and
object areas. See Chan et al. (2018) for further details.
2.4.2. Exposure and test phase
In both experiments mice were exposed to eight objects during the
exposure phase and then were tested 24 h later. In Experiment 1, mice
were divided into 4 groups (N=8 per group): vehicle prior to exposure
and test (Vehicle – Same Test); vehicle prior to exposure and MK-801
prior to test (Vehicle – Diﬀerent Test); MK-801 prior to exposure and
test (MK-801 – Same Test); MK-801 prior to exposure and vehicle prior
to test (MK-801 – Diﬀerent Test). In Experiment 2, mice were divided
into two groups of 16 animals and received either vehicle or MK-801
prior to both exposure and test. The two groups in Experiment 2 con-
tained equal numbers of the mice assigned to the four groups used in
Experiment 1. The experimenter was blind with respect to the group
allocation of the mice. The interval between Experiments 1 and 2 was
14 days.
During the exposure phase mice were placed in the holding arena of
the apparatus. After one minute the central door opened to allow the
mouse to shuttle into the object arena. The mouse was given two
minutes to consume the condensed milk and explore a pair of identical
objects (e.g., A1 and A2) located in the top-left and top-right hand
corners of the apparatus. At the end of the sample trial, the side doors
were opened to allow the mouse to return to the holding arena for one
minute, and to consume the condensed milk. While the mouse waited in
the holding arena, the experimenter changed the objects in the object
arena and the object arena food well was rebaited. After the one minute
interval, the central door was opened and the mouse shuttled to the
object arena and was now allowed to explore a diﬀerent pair of iden-
tical objects (e.g., B1 and B2). This procedure was repeated until a
mouse had been exposed to eight objects (A-H). Twenty-four hours later
mice received the test session that was run in a similar manner to the
exposure phase, except that now mice were allowed to explore a fa-
miliar object and a novel object on each trial (e.g., A and I). New copies
of the familiar objects were used in order to avoid potential odor cues.
Across the eight test trials the familiar objects were presented in the
same order as the exposure phase. The location of the novel object
across trials was equally often left or right for a mouse, but the order of
the locations was random with the constraint that it was not in the same
location more than twice across consecutive trials. For each pair of
novel and familiar objects presented on each trial the identity of the
novel object and its location was counterbalanced across mice within
each group. The order of the object pairs presented across trials was the
same for each mouse. Objects were wiped with 70% Isopropyl alcohol
after each trial, and the arena was cleaned with 70% Isopropyl alcohol
at the end of each day.
2.5. Behavioural data analysis
Object exploration was scored oﬀ-line and the scorer was blind with
respect to the group allocations of the mice and the identities of the
novel objects. Object exploration was deﬁned as the nose of the mouse
being directed towards the object at a distance of less than 1 cm.
Novelty preference was measured using the diﬀerence in the mean
duration of exploration of novel and familiar objects (diﬀerence score:
novel minus familiar) across all eight trials, with positive scores in-
dicating a novelty preference. In addition, diﬀerence scores weighted
by the mean total object exploration time across trials during the test
phase were used to calculate a discrimination ratio with positive ratios
indicating a novelty preference (Ennaceur & Delacour, 1988). The path
length travelled by mice during the exposure and test phases was used
as a measure of locomotor activity. Path lengths were tracked using
Ethovision (Noldus, Netherlands). For between group comparisons data
were analysed with either multi-factorial ANOVA or unpaired t-tests.
One sample t-tests were used to test whether novelty preferences were
signiﬁcantly above chance (i.e., zero for both the diﬀerence scores and
discrimination ratios). In instances in which we were interested in
whether the data provided support for the null hypothesis, Bayes factors
(BF10) were calculated in JASP (JASP Team, 2018) using default priors.
3. Results
3.1. Experiment 1
During the test phase the novelty preference for mice that received
MK-801 during the exposure phase was similar to controls (Fig. 1).
However, mice that received the same drug during both the exposure
and test phases showed a higher preference than mice that were tested
under a drug-state that was diﬀerent from that in the exposure phase,
regardless of whether it was MK-801 or vehicle. A 2 (Drug during ex-
posure: MK-801 or vehicle) by 2 (Drug during test: Same or Diﬀerent)
ANOVA revealed that diﬀerence scores (Fig. 1, left panel) were sig-
niﬁcantly higher when the drug-state at test was the same as exposure
than when it was diﬀerent (F(1, 28)= 8.07, p= 0.008, ηp2= 0.22,
90% CI [0.04, 0.41]). There was no signiﬁcant eﬀect of MK-801 during
exposure (F < 1), and no signiﬁcant interaction between factors
(F < 1). A similar pattern was found with discrimination ratios (Fig. 1,
right panel; same/diﬀerent eﬀect: F(1, 28)= 4.48, p=0.043,
ηp2= 0.14, 90% CI [0.002, 0.33]; eﬀect of drug-state at exposure and
interaction: F values < 1). One sample t-tests for both diﬀerence scores
and discrimination ratios conﬁrmed that the novelty preferences for
mice tested in the same drug-state as exposure and a state that diﬀered
from exposure were signiﬁcantly above chance (smallest t(15)= 5.51,
p < 0.001, ηp2= 0.67, 90% CI [0.36, 0.78]).
Similar ANOVAs were conducted on the levels of object exploration
(Fig. 2) and path lengths (Fig. 3) for both phases. For both measures,
there were no signiﬁcant eﬀects or interactions of factors for either
exposure or test phases (object exploration: largest F= 2.26, p= 0.144
ηp2= 0.07, 90% CI [0.00, 0.25]; path lengths: largest F value=2.50,
p=0.125, ηp2= 0.08, 90% CI [0.00, 0.26]).
3.2. Experiment 2
During the test phase the novelty preference was similar for both
groups (see Fig. 4; diﬀerence score: t(30) < 1; discrimination ratio: t
(30) < 1). In order to assess whether the data supported the null hy-
pothesis, BF10 was calculated for each measure: diﬀerence score,
BF10=0.351; discrimination ratio, BF10=0.345. Therefore, the results
are more than 2.8 times more likely under the null hypothesis than
under the alternative hypothesis. One sample t-tests for both diﬀerence
scores and discrimination ratios conﬁrmed that novelty preferences
were signiﬁcantly above chance for both groups (smallest t(15)= 5.06,
p < 0.001, ηp2= 0.46, 90% CI [0.23, 0.60]).
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There was no signiﬁcant eﬀect of MK-801 on object exploration
(Fig. 5) during exposure (t < 1) or test (t < 1). MK-801 did sig-
niﬁcantly increase path lengths (Fig. 6) during the exposure phase (t
(30)= 5.07, p < 0.001 ηp2= 0.46, 90% CI [0.23, 0.60]) and the test
phase (t(30)= 3.72, p= 0.001, ηp2= 0.32, 90% CI [0.10, 0.49]).
4. Discussion
The aim of the experiments was to test if MK-801 impairs long-term
spontaneous object recognition memory under conditions in which the
state-dependency of memory was controlled. When mice received MK-
801 prior to both the encoding and test phase there was no signiﬁcant
eﬀect on performance. This was true for a low dose (0.01mg/kg) and a
higher dose (0.1 mg/kg). In contrast, in Experiment 1 it was found that,
regardless of the whether mice received vehicle or MK-801 at exposure,
if there was a switch in the drug-state between the exposure and test
phases then performance was lower than when the states were the
same. The impaired performance of object recognition memory when
there was a switch in the drug-state between the exposure and test
phases did not reﬂect general changes in object exploration. Levels of
object exploration were similar between groups for both the exposure
and test phases. The lack of diﬀerence between groups when state-de-
pendency was controlled demonstrates that although the low dose of
MK-801 clearly led to state-dependent eﬀects, it did not aﬀect encoding
or retrieval of memory per se.
The lack of eﬀect of MK-801 on encoding in Experiment 1 is unlikely
to be due to the level of the dose. In Experiment 2 mice received a
higher dose (0.1 mg/kg) that still did not aﬀect performance under
conditions in which the state-dependency of memory was controlled.
The high dose did, however, induce hyperactivity, as indicated by an
increase in path length, demonstrating that the dose used was able to
aﬀect behaviour. Despite this, levels of overall object exploration were
not signiﬁcantly aﬀected by MK-801. It is of course possible that even
higher doses may impair memory under conditions in which state-de-
pendency is controlled, but the scope for ﬁnding such an eﬀect is likely
to be limited due to MK-801 causing ataxia at doses of 0.2mg/kg
(Andine et al., 1999).
The failure to ﬁnd impaired memory performance with the high
dose in Experiment 2 is unlikely to be due to a ﬂoor eﬀect. Given that
control mice showed performance that was signiﬁcantly above chance,
there was scope to observe reduced performance. Furthermore, the
performance of the control mice was comparable to that of controls in
other studies using similar procedures that have been suﬃcient for
demonstrating impaired performance (Sanderson et al., 2011). Baye-
sian analyses provided evidence for the null hypothesis, suggesting that
the lack of eﬀect was unlikely to be due to a failure to observe an im-
pairment. Importantly, the lack of eﬀect of the high dose of MK-801 on
recognition memory performance was in stark contrast to the eﬀect on
locomotor activity, demonstrating that the dose of MK-801 was suﬃ-
cient to aﬀect behavior despite not impairing recognition memory
performance.
The results are in agreement with other studies that have found that
MK-801 has state-dependent eﬀects on memory (Ceretta et al., 2008;
Flint et al., 2013; Jackson et al., 1992). Due to a lack of eﬀect of MK-
801 in our experiments when state-dependency was controlled, con-
clusions that can be drawn from studies that have not included state-
dependent controls are limited. There are, however, studies that have
shown MK-801 does aﬀect memory performance when state-de-
pendency is not likely to be an issue. It is of particular importance for
the present study that MK-801 impairs object recognition memory
when the interval between the exposure and test phases is suﬃciently
short such that both phases occur during the same exposure to the drug
(de Lima et al., 2005; Nilsson et al., 2007; Oh et al., 2017; Olszewski
et al., 2012; van der Staay et al., 2011). In these procedures, not only
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Fig. 2. MK-801 (0.01mg/kg) failed to aﬀect levels object exploration. Left panel: Cumulative duration of object exploration in the exposure phase. Right panel:
Cumulative duration of object exploration in the test phase. Error bars indicate SEM.
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exposure phase. Right panel: Path length in the test phase. Error bars indicate SEM.
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are the exposure and test phases conducted under the same drug-state,
but the short retention interval results in short-term memory being
assessed. This may suggest that MK-801 impairs short-term object re-
cognition memory, but not long-term object memory. It has been sug-
gested that short-term recognition memory relies on a short-term
memory trace that is activated by exploration of an object, whereas
long-term recognition memory relies on associative retrieval of memory
caused by contextual cues (Robinson & Bonardi, 2015; Sanderson,
2016; Wagner, 1981). Thus it is possible that MK-801 impairs short-
term memory activation caused by recent experience of a stimulus, but
does not aﬀect associative retrieval of memory. This conclusion is,
however, at odds with the ﬁndings of Barker et al. (2006), who found
that NMDA receptors in the perirhinal cortex, manipulated by the se-
lective NMDA receptor antagonist AP-5, were not necessary for short-
term object recognition with a retention interval of 20 mins. This dis-
crepancy may reﬂect diﬀerences in the methods used to manipulate
NMDA receptors. It is also possible that NMDA receptors in other brain
regions may be responsible for the eﬀects found with systemic admin-
istration of MK-801. Barker et al. (2006) did ﬁnd, however, that AP-5
infused into the perirhinal cortex prior to encoding impaired perfor-
mance after a 24-hour test interval, but performance during the test was
examined in the absence of the drug. Therefore, the impaired perfor-
mance may reﬂect a state-dependent eﬀect on memory expression ra-
ther than impaired encoding of long-term memory.
The absence of an eﬀect of MK-801 on object recognition memory
under conditions in which state-dependency of memory is controlled
suggests that the role of NMDA receptors in learning and memory may
be more limited than previously thought. While NMDA receptors are
necessary for synaptic plasticity within regions implicated in learning
and memory it is possible that their role is not always necessarily in
encoding or retrieval, but perhaps in other aspects of cognition that
aﬀect behaviour. For example, recent evidence has shown the NMDA
receptors in the CA1 and dentate gyrus regions of the hippocampus are
not necessary for spatial learning, but mice that lack NMDA receptors in
those regions fail to express learning in circumstances in which am-
biguous cues compete for control of behavior (Bannerman et al., 2012).
Therefore, the role of NMDA receptors and NMDA receptor-dependent
long-term potentiation may not be in acquisition of memory, but in
factors that aﬀect behavioural expression of memory (Bannerman et al.,
2014).
Assessment of object recognition memory was optimised in the
present study using a procedure that increased the sensitivity of the
measure by exposing mice to multiple objects and decreased potential
stress by minimizing handling of the mice (Chan et al., 2018). The
procedure was adapted from that used by Chan et al. (2018) in order to
test performance over a long, 24 h interval and to test the eﬀect of drugs
on diﬀerent stages of the object recognition procedure. While the
spontaneous novel object preference procedure is widely used as a
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Fig. 5. MK-801 (0.1mg/kg) failed to aﬀect levels object exploration. Left panel: Cumulative duration of object exploration in the exposure phase. Right panel:
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measure of memory in rodents (Ennaceur, 2010; Lyon, Saksida, &
Bussey, 2012) it often suﬀers from a lack of sensitivity due to the in-
herent variability of unconditioned behavior between and within ani-
mals (Ameen-Ali, Easton, & Eacott, 2015; Gaskin et al., 2010;
Kinnavane, Albasser, & Aggleton, 2015). The results of the present
study demonstrate that the multiple-trials procedure allows a measure
of memory that is suﬃciently sensitive to reveal diﬀerences in perfor-
mance of mice that diﬀer in their current drug-state. Therefore, this
procedure is a new viable method for testing the eﬀect of the drugs and
other neural manipulations on dissociable components of memory such
as encoding and expression.
In conclusion, the results demonstrate that MK-801 fails to impair
expression of long-term memory in the object recognition procedure
when the state-dependency of memory is controlled. Therefore, MK-801
does not appear to aﬀect encoding of long-term memory, but induces a
state that can aﬀect the expression of memory when the drug-state
diﬀers between encoding and retrieval of memory.
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